MAKENZIE SHEVLIN: Open Payments
NPI 1841906500 · PALM BEACH GARDENS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,245 in 100 payments from 16 companies in 2025. Trend: 2023 $1,614 · 2024 $2,184 · 2025 $2,245
Food & beverage: $2,245
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $310 |
| Neurocrine BioSciences, Inc. | 9 | $267 |
| E.R. Squibb & Sons, L.L.C. | 10 | $207 |
| Janssen Pharmaceuticals, Inc | 8 | $199 |
| Vanda Pharmaceuticals Inc. | 6 | $169 |
| LivaNova USA, Inc. | 3 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $148 |
| Lundbeck LLC | 7 | $139 |
| Teva Pharmaceuticals USA, Inc. | 7 | $124 |
| Corium, LLC | 8 | $119 |
Products named: VRAYLAR, INGREZZA, REXULTI, COBENFY, FANAPT, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, CAPLYTA, SPRAVATO.
Industry payments across FL — which companies pay providers there.
